MedTrace Logo

Real Life Long-term Adherence to Ticagrelor After PCI for Acute Coronary Syndromes

NCT02265068 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 700

Last updated 2018-06-14

No results posted yet for this study

Summary

Documentation of long-term data regarding ticagrelor use and evaluation of reasons for discontinuation of ticagrelor in patients with ACS

Conditions

  • Acute Coronary Syndrome (ACS)

Interventions

DRUG

Ticagrelor

Treatment of ACS patients with Ticagrelor

Sponsors & Collaborators

  • IHF GmbH - Institut für Herzinfarktforschung

    lead OTHER

Principal Investigators

  • Uwe Zeymer, Prof. Dr. · Klinikum Ludwigshafen, Stiftung IHF - Institut für Herzinfarktforschung

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-08-31
Primary Completion
2016-12-31
Completion
2016-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02265068 on ClinicalTrials.gov